The data represent outcomes of 6 months of combination therapy (ibrutinib+BR or placebo+BR) followed by >2 years of continuous ibrutinib or placebo treatment. For consistency with the initial analysis, the treatment arms are referred to as ibrutinib+BR and placebo+BR.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with F.
Contact F., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack